Patent Applications published on Sep 4, 2025 - page 2

#301
US20250275794A1
Human necessities

FRACTURE PLATING SYSTEMS AND METHODS

#302
US20250275795A1
Human necessities

PACKAGE FOR MEDICAL DEVICES

#303
US20250275796A1
Human necessities

FRACTURE PLATING SYSTEMS AND METHODS

#304
US20250275797A1
Human necessities

TENSIONING INSTRUMENTS

#305
US20250275798A1
Human necessities

Femoral Neck Fracture Fixation Device

#306
US20250275799A1
Human necessities

Screw Inserter

#307
US20250275800A1
Human necessities

PERCUTANEOUS TARGETING DEVICE

#308
US20250275801A1
Human necessities

A SURGICAL DEVICE WITH AIRFLOW AND LIGHT

#309
US20250275802A1
Human necessities

DEVICES AND RELATED METHODS FOR ELECTROSURGERY

#310
US20250275803A1
Human necessities

USER INTERFACE AND LOCK FEATURES FOR POSITIONING MULTIPLE COMPONENTS WITHIN A BODY

#311
US20250275804A1
Human necessities

BIPOLAR DISSECTOR

#312
US20250275805A1
Human necessities

RADIOFREQUENCY ABLATION ELECTRODE, USE THEREOF AND RADIOFREQUENCY ABLATION SYSTEM

#313
US20250275806A1
Human necessities

TISSUE EXTRACTION DEVICES AND METHODS

#314
US20250275807A1
Human necessities

CATHETER AND HANDLE ASSEMBLY, SYSTEMS, AND METHODS

#315
US20250275808A1
Human necessities

SYSTEMS AND METHODS FOR PREDICTING THROMBOSIS FOR HEART VALVE REPLACEMENTS

#316
US20250275809A1
Human necessities

KNEE ARTHROPLASTY METHOD

#317
US20250275810A1
Human necessities

SYSTEMS AND METHODS FOR NAVIGATING HIDDEN ANATOMIC PASSAGEWAYS

#318
US20250275811A1
Human necessities

ELECTROMAGNETIC SENSOR

#319
US20250275812A1
Human necessities

SYSTEM AND METHODS FOR PLANNING AND PERFORMING THREE-DIMENSIONAL HOLOGRAPHIC INTERVENTIONAL PROCEDURES WITH THREE-DIMENSIONAL TOMOGRAPHIC AND LIVE IMAGING

#320
US20250275813A1
Human necessities

NAVIGATION AT ULTRA LOW TO HIGH FREQUENCIES

#321
US20250275814A1
Human necessities

METHOD OF FLUOROSCOPIC SURGICAL REGISTRATION

#322
US20250275815A1
Human necessities

FUNCTIONAL INDICATORS FOR ROBOTIC MEDICAL SYSTEMS

#323
US20250275816A1
Human necessities

ROBOTIC SURGICAL SYSTEM, CONTROL METHOD FOR ROBOTIC SURGICAL SYSTEM, AND STORAGE MEDIUM

#324
US20250275817A1
Human necessities

INTERFACE FOR CONNECTING A DRIVE UNIT TO A MEDICAL INSTRUMENT

#325
US20250275818A1
Human necessities

SYSTEMS AND METHODS FOR INTRAOPERATIVE RE-REGISTRATION

#326
US20250275819A1
Human necessities

SINGLE-ARM ROBOTIC DEVICE WITH COMPACT JOINT DESIGN AND RELATED SYSTEMS AND METHODS

#327
US20250275820A1
Human necessities

ADJUSTABLE USER CONSOLE FOR A SURGICAL ROBOTIC SYSTEM

#328
US20250275821A1
Human necessities

METHODS AND DEVICES FOR TELE-SURGICAL TABLE REGISTRATION

#329
US20250275822A1
Human necessities

ROBOTIC SURGICAL SYSTEM, CONTROL METHOD FOR ROBOTIC SURGICAL SYSTEM, AND STORAGE MEDIUM

#330
US20250275823A1
Human necessities

ROBOTIC SURGICAL SYSTEM, CONTROL METHOD FOR ROBOTIC SURGICAL SYSTEM, AND STORAGE MEDIUM

#331
US20250275824A1
Human necessities

APPARATUS AND METHODS FOR TARGETED NAVIGATION

#332
US20250275825A1
Human necessities

DEVICES, SYSTEMS, AND METHODS FOR MAINTAINING A STERILE SURGICAL FIELD

#333
US20250275826A1
Human necessities

ADJUSTABLE DEPTH STOP SYSTEM FOR SURGICAL ACCESSORY

#334
US20250275827A1
Human necessities

RETRACTING TISSUE

#335
US20250275828A1
Human necessities

SURGICAL SKIN MARKER

#336
US20250275829A1
Human necessities

ARTICULATION MECHANISMS FOR INSTRUMENTS, AND RELATED DEVICES AND METHODS

#337
US20250275830A1
Human necessities

MODULAR CLAMPS FOR MOUNTING SURGICAL MANIPULATORS

#338
US20250275831A1
Human necessities

SURGICAL HF DEVICE AND METHOD FOR IDENTIFYING AND OPERATING SURGICAL HF INSTRUMENTS

#339
US20250275832A1
Human necessities

End Cut of Endodontic Brush

#340
US20250275833A1
Human necessities

PROCESSING 2D INTRAORAL IMAGES AND RENDERING NOVEL VIEWS OF PATIENTS

#341
US20250275834A1
Human necessities

SYSTEM, METHOD, AND PALATAL EXPANSION SUPPORT KIT FOR TREATING ORTHODONTIC MISALIGNMENT IN USERS

#342
US20250275835A1
Human necessities

Modelling Protocol for Root Analogue Dental Implants

#343
US20250275836A1
Human necessities

Inter Dental Implant

#344
US20250275837A1
Human necessities

IMPRESSION MODEL SYSTEM AND COMPONENTS

#345
US20250275838A1
Human necessities

DENTAL CROWN MODEL GENERATION METHOD AND DENTAL CROWN MODEL GENERATION SYSTEM

#346
US20250275839A1
Human necessities

BLANK AND METHOD FOR MANUFACTURING THE SAME

#347
US20250275840A1
Human necessities

4D TOOTH MODELING SYSTEM AND METHOD FOR MODELING TEETH IN 4D VIA MOBILE DEVICE-BASED RGB VIDEO AND OPTICAL SENSING TECHNOLOGY

#348
US20250275841A1
Human necessities

INTRAORAL DEVICE

#349
US20250275842A1
Human necessities

ORAL CARING DEVICE

#350
US20250275843A1
Human necessities

Sensing Complete Injection for Animal Injection Device

#351
US20250275844A1
Human necessities

EXTERNAL MALE INCONTINENCE CLAMP

#352
US20250275845A1
Human necessities

Prosthetic Heart Valve Packaging and Attachment Assembly

#353
US20250275846A1
Human necessities

EMBOLIC PROTECTION FOR MITRAL AND TRICUSPID VALVE PROCEDURES

#354
US20250275847A1
Human necessities

Spiral Flow-Inducing Exo-Graft

#355
US20250275848A1
Human necessities

BYPASS GRAFT

#356
US20250275849A1
Human necessities

THORACOAORTIC HYBRID GRAFT AND SURGICAL METHODS THEREOF

#357
US20250275850A1
Human necessities

TENDON REPAIR SYSTEM

#358
US20250275851A1
Human necessities

ANCHOR POSITION VERIFICATION FOR PROSTHETIC CARDIAC VALVE DEVICES

#359
US20250275852A1
Human necessities

Transcatheter Prosthetic Venous Valve Assemblies and Associated Catheter Delivery Systems and Methods

#360
US20250275853A1
Human necessities

LEAFLET CLAMPING MEMBERS

#361
US20250275854A1
Human necessities

VALVE DELIVERY DEVICE

#362
US20250275855A1
Human necessities

IMPLANTABLE EXPANDABLE BONE SUPPORT DEVICE

#363
US20250275856A1
Human necessities

IMPLANTS HAVING BONE GROWTH PROMOTING AGENTS AND METHODS OF USING SUCH IMPLANTS TO REPAIR BONE STRUCTURES

#364
US20250275857A1
Human necessities

ANTERIOR LUMBAR INTERBODY FUSION DEVICE WITH BIDIRECTIONAL SCREWS

#365
US20250275858A1
Human necessities

MACHINE-LEARNED MOVEMENT DETERMINATION BASED ON INTENT IDENTIFICATION

#366
US20250275859A1
Human necessities

LAYERED MEDICAL APPLIANCES AND METHODS

#367
US20250275860A1
Human necessities

LOCKING ASSEMBLY FOR COUPLING GUIDEWIRE TO DELIVERY SYSTEM

#368
US20250275861A1
Human necessities

DELIVERY SYSTEMS FOR STENTS HAVING PROTRUDING FEATURES

#369
US20250275862A1
Human necessities

Lip-based user interface system

#370
US20250275863A1
Human necessities

ANKLE/FOOT ORTHOSIS

#371
US20250275864A1
Human necessities

Wearable Urinary Collection Apparatus

#372
US20250275865A1
Human necessities

AN UROSTOMY BAG WITH A SENSOR TO DETERMINE AND COMMUNICATE A URINE LEVEL TO USER

#373
US20250275866A1
Human necessities

METHOD AND APPARATUS FOR REDUCING VULVOVAGINAL PAIN

#374
US20250275867A1
Human necessities

LUBRICATION ASSEMBLY AND METHOD FOR USE THEREOF

#375
US20250275868A1
Human necessities

INFUSION DEVICE AND METHOD

#376
US20250275869A1
Human necessities

SYSTEM FOR SHAPING AND IMPLANTING BIOLOGIC INTRAOCULAR STENT FOR INCREASED AQUEOUS OUTFLOW AND LOWERING OF INTRAOCULAR PRESSURE

#377
US20250275870A1
Human necessities

OCULAR IMPLANTS FOR DELIVERY INTO AN ANTERIOR CHAMBER OF THE EYE

#378
US20250275871A1
Human necessities

DEVICES AND METHODS FOR IMPROVED REMOVAL OF CORTICAL MATERIAL

#379
US20250275872A1
Human necessities

Apparatuses and Methods for Improving Post-Operative Recovery from Surgery

#380
US20250275873A1
Human necessities

Chest Seal

#381
US20250275874A1
Human necessities

COMPRESSION SOCK WITH INTEGRATED DONNING AND DOFFING AID SYSTEM

#382
US20250275875A1
Human necessities

CAREGIVER OPERATED MOBILITY SCOOTER DEVICE

#383
US20250275876A1
Human necessities

DEVICE TO FACILITATE THE TRANSPORT OR STORAGE OF ITEMS BY A PERSON SEATED IN A WHEELCHAIR OR USING OTHER MOBILE DEVICES

#384
US20250275877A1
Human necessities

NEONATAL SUPPORT SYSTEM

#385
US20250275878A1
Human necessities

RELOCATION MODULE AND METHODS FOR SURGICAL EQUIPMENT

#386
US20250275879A1
Human necessities

THERAPY DEVICE HAVING A QUICK-CHANGE ADAPTER AND QUICK-CHANGE ADAPTER

#387
US20250275880A1
Human necessities

A GARMENT ASSEMBLY FOR TRIGGERING, FACILITATING OR RESISTING MOVEMENT

#388
US20250275881A1
Human necessities

FLUID-POWERED ARTIFICIAL MUSCLE OR MUSCLES FOR COMPRESSION APPLICATIONS

#389
US20250275882A1
Human necessities

LIGHT THERAPY SYSTEM

#390
US20250275883A1
Human necessities

NECK MASSAGER

#391
US20250275884A1
Human necessities

ELECTROMAGNETICALY DRIVEN CHASSIS ASSEMBLY AND RHYTHMIC FURNITURE

#392
US20250275885A1
Human necessities

NECK MASSAGE DEVICE WITH DUAL ARC-SHAPED RIGID CLAMPING PLATES

#393
US20250275886A1
Human necessities

MASSAGE DEVICE WITH DUAL RIGID CLAMP PLATES

#394
US20250275887A1
Human necessities

MECHANICAL CARDIO PULMONARY RESUSCITATION DEVICE HAVING A CONTACT MEMBER

#395
US20250275888A1
Human necessities

SAUNA

#396
US20250275889A1
Human necessities

CONTAINER FOR IRRIGATION APPLICATION COMPRISING A PRECISELY DEFINED OPENING AND A PRODUCTION PROCESS THEREOF

#397
US20250275890A1
Human necessities

VIAL ADAPTER AND VIAL ADAPTER SYSTEM AND METHOD

#398
US20250275891A1
Human necessities

Sensor system, assembly, method and computer program product for detecting events in an automatic dispensing process of discrete medicaments

#399
US20250275892A1
Human necessities

COSMETIC COATING DEVICE

#400
US20250275893A1
Human necessities

PERFUME GEL COMPOSITION

#401
US20250275894A1
Human necessities

STABLE FOAMED CLEANSING COMPOSITION AND METHODS OF USE

#402
US20250275895A1
Human necessities

ELECTROSTATICALLY SPRAYABLE TANNING FORMULATION

#403
US20250275896A1
Human necessities

WHIPPED FORMULATIONS WITH DESIRED SENSORY IMPACT

#404
US20250275897A1
Human necessities

CONCENTRATED COMPOSITION AND USES OF SAME

#405
US20250275898A1
Human necessities

MIXTURE OF STABILIZED STANNOUS IONS COMPLEX FOR HIGH-WATER CONTENT ORAL CARE PRODUCT

#406
US20250275899A1
Human necessities

SILICA PARTICLE AND PREPARATION METHOD THEREOF, AND ORAL CLEANING AND CARE COMPOSITION

#407
US20250275900A1
Human necessities

HAIR REMOVAL COMPOSITION DISPENSABLE FROM A SPRAY CAN

#408
US20250275901A1
Human necessities

NON-FLAMMABLE, DRY PERSONAL CARE PRODUCT CONTAINING trans-1233zd AND ETHANOL

#409
US20250275902A1
Human necessities

COMPOSITION COMPRISING BIOSURFACTANT AND SALICYLIC ACID

#410
US20250275903A1
Human necessities

COMPOSITION COMPRISING BIOSURFACTANT AND SALICYLIC ACID

#411
US20250275904A1
Human necessities

ANTI-SUN COSMETIC COMPOSITION CONTAINING MYCOSPORINE-LIKE AMINO ACIDS

#412
US20250275905A1
Human necessities

ANTIBACTERIAL AND MINERALIZING COMPOSITIONS AND METHODS OF USE THEREOF

#413
US20250275906A1
Human necessities

METHOD FOR PREPARING LYOPHILIZED COLLAGEN POWDER AND USE THEREOF

#414
US20250275907A1
Human necessities

STABLE MOISTURIZER

#415
US20250275908A1
Human necessities

COSMETIC COMPOSITION FOR ACNE CARE

#416
US20250275909A1
Human necessities

COSMETIC COMPOSITION COMPRISING MICA AND LAUROYL LYSINE

#417
US20250275910A1
Human necessities

Cosmetic application of viniferine

#418
US20250275911A1
Human necessities

Cosmetic Composition Containing an Extract of Gentiana and Leontopodium and/or Centella

#419
US20250275912A1
Human necessities

NOVEL COMPOSITION FOR IMPROVEMENT OF HAIR AND SCALP CONDITION

#420
US20250275913A1
Human necessities

HAIR, SCALP AND SKIN TREATMENT COMPOSITIONS

#421
US20250275914A1
Human necessities

PREPARATION METHOD AND CONTAINER FOR A TOPICAL WOUND HEALING GEL

#422
US20250275915A1
Human necessities

COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS

#423
US20250275916A1
Human necessities

MEDICATED EYELID CLEANSING COMPOSITIONS

#424
US20250275917A1
Human necessities

TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION

#425
US20250275918A1
Human necessities

LIPID COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY

#426
US20250275919A1
Human necessities

NANOTUBE-VESICLE COMPOSITIONS AND USES THEREOF

#427
US20250275920A1
Human necessities

Method of Safe Administration of Phosphorylated TAU Peptide Vaccine

#428
US20250275921A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING LIPID NANOPARTICLES

#429
US20250275922A1
Human necessities

THERMOSTABLE PARTICLE-BASED COMPOSITIONS AND MANUFACTURING PROCESS

#430
US20250275923A1
Human necessities

SINGLE LAYER CHEWABLE TABLET COMPRISING CETIRIZINE

#431
US20250275924A1
Human necessities

Anticholinergic Agents and Muscarinic Agonists for the Treatment of Demodex Related Conditions

#432
US20250275925A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF NOR-UDCA

#433
US20250275926A1
Human necessities

MULTILAYER FORMULATION COMPRISING MODIFIED TAPIOCA STARCH FOR CONTROLLED-RELEASE OF ACTIVE AGENTS

#434
US20250275927A1
Human necessities

SOLID DOSAGE FORM PRODUCTION

#435
US20250275928A1
Human necessities

NANOPARTICLE-BASED ABUSE-DETERRENT FORMULATIONS AND METHODS OF MAKING AND USING

#436
US20250275929A1
Human necessities

INTRAOPERATIVE TOPICALLY-APPLIED NON-IMPLANTABLE RAPID RELEASE PATCH

#437
US20250275930A1
Human necessities

TRANSDERMAL DELIVERY PATCH FOR TREATING PAIN

#438
US20250275931A1
Human necessities

TOPICAL PATCH COMPOSITION FOR TARGETED SIRNA NANOPLEX DELIVERY AND GENE THERAPIES AND METHOD OF MAKING AND USE THEREOF

#439
US20250275932A1
Human necessities

TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIB

#440
US20250275933A1
Human necessities

METHODS FOR MAKING AND USING PHARMACEUTICAL COMPOSITIONS FOR IONTOPHORESIS

#441
US20250275934A1
Human necessities

MEDICAMENTS FOR SLOWING PARKINSON'S DISEASE

#442
US20250275935A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH DEMENTIA DUE TO ALZHEIMER'S DISEASE WITH A COMBINATION OF THC AND MELATONIN

#443
US20250275936A1
Human necessities

METHOD FOR TREATING CANCERS AND NEUROLOGICAL DISEASES USING QUERCETIN-CONTAINING COMPOSITIONS

#444
US20250275937A1
Human necessities

Methods For Reducing Negative Effects Of Alcohol Consumption

#445
US20250275938A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

#446
US20250275939A1
Human necessities

CO-CRYSTALS

#447
US20250275940A1
Human necessities

PTEROSTILBENE AND SILIBININ FOR PREVENTING, AMELIORATING OR REDUCING RADIATION-INDUCED DISEASES

#448
US20250275941A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS

#449
US20250275942A1
Human necessities

STING AGONISTS, FORMULATIONS, AND USES THEREOF

#450
US20250275943A1
Human necessities

COMPOSITION FOR CANCER DIAGNOSIS TARGETING TUMOR AND/OR TUMOR MICROENVIRONMENT AND USE THEREOF

#451
US20250275944A1
Human necessities

RELATIVE UNDERSUPPLY OF AN AMYLOID BETA AGGREGATION INHIBITOR FOR IMPROVED DETOXIFYING EFFECTS

#452
US20250275945A1
Human necessities

COMPOUNDS FOR TREATING TNBC

#453
US20250275946A1
Human necessities

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#454
US20250275947A1
Human necessities

COMPOSITIONS AND METHODS OF USING A DIHYDROISOXAZOLE COMPOUND THAT REDUCES ECTOPARASITE INFESTATIONS ON FISH

#455
US20250275948A1
Human necessities

(N-[4-(2,3-DIHYDRO-1H-INDEN-5-YL)-1,3-THIAZOL-2-YL]-2-[4-METHYL-4-(NAPHTHALEN-2-YL)-2,5-DIOXOIMIDAZOLIDIN-1-YL]ACETAMIDE AS STABILIZER OF CLOCK:BMAL1 INTERACTION FOR THE TREATMENT OF CIRCADIAN RHYTHM DISEASES AND DISORDERS

#456
US20250275949A1
Human necessities

USE OF DITERPENE COMPOUND DERIVATIVE OR SALT THEREOF IN PREPARATION OF MEDICINE FOR PREVENTING AND TREATING ATOPIC DERMATITIS

#457
US20250275950A1
Human necessities

RIFAXIMIN AND N-ACETYL CYSTEINE FORMULATIONS

#458
US20250275951A1
Human necessities

DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES

#459
US20250275952A1
Human necessities

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

#460
US20250275953A1
Human necessities

VODOBATINIB FOR REDUCING PROGRESSION OF PARKINSON'S DISEASE

#461
US20250275954A1
Human necessities

USE OF KYNURENIC ACID RESISTING HYPERURICEMIA AND STRUCTURAL ANALOG THEREOF IN PREPARATION OF XOD INHIBITOR

#462
US20250275955A1
Human necessities

USE OF TIVOZANIB TO TREAT SUBJECTS WITH REFRACTORY CANCER

#463
US20250275956A1
Human necessities

TREATMENT OF CNS TUMORS WITH OLUTASIDENIB AND TEMOZOLOMIDE

#464
US20250275957A1
Human necessities

METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER

#465
US20250275958A1
Human necessities

GPCR REGULATOR AND USE THEREOF

#466
US20250275959A1
Human necessities

COMPOUNDS AND METHODS OF THEIR USE

#467
US20250275960A1
Human necessities

TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASE

#468
US20250275961A1
Human necessities

BROMOCRIPTINE FORMULATIONS

#469
US20250275962A1
Human necessities

TRANSMUCOSAL METHODS FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS

#470
US20250275963A1
Human necessities

DRY EYE TREATMENTS

#471
US20250275964A1
Human necessities

METHODS OF INHIBITING LIVER-TYPE GLUTAMINASE, GLS2

#472
US20250275965A1
Human necessities

COMPOUNDS AS CASEIN KINASE INHIBITORS

#473
US20250275966A1
Human necessities

GABAA RECEPTOR MODULATOR SALTS, PARTICLES, AND USES THEREOF

#474
US20250275967A1
Human necessities

FREEZE DRIED COMPOSITIONS

#475
US20250275968A1
Human necessities

INHIBITORS OF TAU PROTEINS

#476
US20250275969A1
Human necessities

METHODS OF TREATING MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) USING LSD1 INHIBITORS

#477
US20250275970A1
Human necessities

SMARCA DEGRADERS AND USES THEREOF

#478
US20250275971A1
Human necessities

CDK INHIBITORS

#479
US20250275972A1
Human necessities

CDK INHIBITORS

#480
US20250275973A1
Human necessities

USE OF ALC1 INHIBITORS AND SYNERGY WITH PARPI

#481
US20250275974A1
Human necessities

TREATMENT OF FRONTAL FIBROSING ALOPECIA

#482
US20250275975A1
Human necessities

Methods of Treating Neuropathies

#483
US20250275976A1
Human necessities

Methods of Treating Neuroinflammatory Conditions

#484
US20250275977A1
Human necessities

DOSAGE REGIMENS FOR TREATMENT WITH DEUTERATED JAK INHIBITORS

#485
US20250275978A1
Human necessities

USE OF ONVANSERTIB AS MONOTHERAPY AND IN COMBINATION WITH CETUXIMAB IN TREATING RAS WILD-TYPE COLORECTAL CANCER

#486
US20250275979A1
Human necessities

TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS

#487
US20250275980A1
Human necessities

METHYLTHIONINIUM SALT-CONTAINING COMPOSITIONS AND METHODS

#488
US20250275981A1
Human necessities

HOMOHARRINGTONINE AND PACLITAXEL COMBINATION FOR THE TREATMENT OF BREAST CANCER

#489
US20250275982A1
Human necessities

SOLID FORM FORMULATION COMPRISING CHROMIUM OR COPPER OR A VITAMIN, COMPOSITIONS AND USES THEREOF

#490
US20250275983A1
Human necessities

D2O STABILIZED PHARMACEUTICAL FORMULATIONS

#491
US20250275984A1
Human necessities

ORAL SURGERY DRUG

#492
US20250275985A1
Human necessities

COMPOSITIONS FOR IMPROVING CELL VIABILITY AND METHODS OF USE THEREOF

#493
US20250275986A1
Human necessities

COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT

#494
US20250275987A1
Human necessities

MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR USE IN THE TREATMENT OF COGNITIVE DECLINE

#495
US20250275988A1
Human necessities

FORMULATION FOR TREATING URINARY SYSTEM DISORDERS

#496
US20250275989A1
Human necessities

9-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USES THEREOF

#497
US20250275990A1
Human necessities

ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS

#498
US20250275991A1
Human necessities

ORAL COMPLEMENT FACTOR D INHIBITORS

#499
US20250275992A1
Human necessities

TOPICAL FORMULATIONS FOR THERAPEUTICALLY ACTIVE AGENTS

#500
US20250275993A1
Human necessities

GLYCOSYLATION INHIBITORS AS THERAPEUTICS FOR STROKE

#501
US20250275994A1
Human necessities

Quinoline Derivatives For Use In The Treatment Of Inflammation Diseases

#502
US20250275995A1
Human necessities

NICOTINAMIDE RIBOSIDE DOSAGE REGIMEN FOR TREATING PARKINSON'S DISEASE

#503
US20250275996A1
Human necessities

COMBINATION OF TUNICAMYCIN-TYPE ANTIBIOTIC WITH POLYMYXINS AND USES THEREOF

#504
US20250275997A1
Human necessities

Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester

#505
US20250275998A1
Human necessities

COMPOSITIONS FOR PROMOTING LONGEVITY AND METHODS OF USING THE SAME

#506
US20250275999A1
Human necessities

HIGH PURITY RNA COMPOSITIONS AND METHODS FOR PREPARATION THEREOF

#507
US20250276000A1
Human necessities

METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS

#508
US20250276001A1
Human necessities

SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

#509
US20250276002A1
Human necessities

Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders

#510
US20250276003A1
Human necessities

PARMELIA TINCTORUM POLYSACCHARIDE XEP-70, METHOD OF PREPARATION, AND USE THEREOF

#511
US20250276004A1
Human necessities

HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR TREATMENT AND PREVENTION OF SEVERE OCULAR SURFACE DISEASE

#512
US20250276005A1
Human necessities

POLYSACCHARIDES FOR IV ADMINISTRATION THAT TREAT SARS-COV-2 INFECTIONS

#513
US20250276006A1
Human necessities

ANTICORONAVIRAL AGENT

#514
US20250276007A1
Human necessities

CARBAMOYLPHENYLBORONIC ACID-CONTAINING ACRYLIC MONOMERS AND USES THEREOF

#515
US20250276008A1
Human necessities

USE OF LITHIUM-CONTAINING COMPOUNDS IN TREATMENT OF TUMORS

#516
US20250276009A1
Human necessities

Therapeutic use of hydrogen sulfide in frostbite injury

#517
US20250276010A1
Human necessities

MATERIALS CONTAINING COPPER AND THEIR USE IN BENEFICIAL BODY HEALTH

#518
US20250276011A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES

#519
US20250276012A1
Human necessities

NOVEL CAR T-CELL PRODUCT AND METHOD OF PREPARATION THEREOF

#520
US20250276013A1
Human necessities

Cells Modified by Conjugated N-Terminal Glycine and Uses Thereof

#521
US20250276014A1
Human necessities

GENETICALLY ENGINEERED INNATE LYMPHOID CELLS FOR ENHANCING LIFESPAN AND/OR TREATING CANCERS

#522
US20250276015A1
Human necessities

RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2

#523
US20250276016A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR AND IL-18 RECEPTOR COMPOSITIONS AND METHODS OF USE THEREIN

#524
US20250276017A1
Human necessities

Compositions and Methods for Genomic Editing

#525
US20250276018A1
Human necessities

CAR CONSTRUCTS AND METHODS OF TREATMENT

#526
US20250276019A1
Human necessities

METHODS FOR PREPARING PLATELET RELEASATE

#527
US20250276020A1
Human necessities

DUAL MACROGLIAL-MICROGLIAL APPROACH TOWARDS THERAPEUTIC CELL REPLACEMENT IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISEASE

#528
US20250276021A1
Human necessities

ISOLATION, ENRICHMENT, AND EXPANSION OF HUMAN ROD PROGENITOR CELLS AND EXTRACELLULAR VESICLES DERIVED THEREFROM

#529
US20250276022A1
Human necessities

DENTIN MATRIX PROTEIN MATERIALS AND ASSOCIATED METHODS

#530
US20250276023A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY IN BUILT ENVIRONMENTS

#531
US20250276024A1
Human necessities

A METHOD OF CELL REJUVENATION

#532
US20250276025A1
Human necessities

APPLICATION OF BIFIDOBACTERIUM ANIMALIS IN IMPROVEMENT OF TUMOR IMMUNOTHERAPY RESPONSE

#533
US20250276026A1
Human necessities

TRANSIENT COMMENSAL MICROORGANISM FOR IMPROVING GUT HEALTH

#534
US20250276027A1
Human necessities

LACTOBACILLUS COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF MICROBIAL INFECTION

#535
US20250276028A1
Human necessities

COMPOSITION FOR REDUCING SIZE OR VOLUME OF TARGET TISSUE OR KIT INCLUDING SAME

#536
US20250276029A1
Human necessities

ANTIBACTERIAL AND ANTIOXIDANT COMPOSITION CONTAINING GRAPE CALLUS CULTURE MEDIUM AS ACTIVE INGREDIENT

#537
US20250276030A1
Human necessities

EOM613 FOR TREATMENT OF COVID-19

#538
US20250276031A1
Human necessities

PRODRUGS AS SELECTIVE ANTIBIOTICS AGAINST COLIBACTIN-PRODUCING E. COLI

#539
US20250276032A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT

#540
US20250276033A1
Human necessities

COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME

#541
US20250276034A1
Human necessities

RELEASE-CONTROLLED TOPICAL INJECTION COMPOSITION CONTAINING CYCLIC PEPTIDE AND PREPARATION METHOD THEREFOR

#542
US20250276035A1
Human necessities

ANTIBACTERIAL POLYPEPTIDES

#543
US20250276036A1
Human necessities

COMPOSITION FOR THE INHIBITION OF NRF2 AND USES THEREOF IN CANCER THERAPY

#544
US20250276037A1
Human necessities

METHODS OF TREATING FRIEDREICH'S ATAXIA

#545
US20250276038A1
Human necessities

HISTATIN COMBINATIONS AND METHODS FOR TREATING OR INHIBITING CELL LOSS

#546
US20250276039A1
Human necessities

METHOD OF ENHANCING ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC)

#547
US20250276040A1
Human necessities

IL7-IL15 TxM Compositions and Methods

#548
US20250276041A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES

#549
US20250276042A1
Human necessities

METHOD FOR REDUCING FLU-LIKE SYMPTOMS ASSOCIATED WITH INTRAMUSCULAR ADMINISTRATION OF INTERFERON USING A FAST TITRATION ESCALATING DOSING REGIMEN

#550
US20250276043A1
Human necessities

Pharmaceutical Composition Containing GLP-1 Compound

#551
US20250276044A1
Human necessities

COMBINATION THERAPY COMPRISING GLP-2, AND INSULINOTROPIC PEPTIDE, TNFa INHIBITOR, OR BOTH FOR PREVENTING OR TREATING BOWEL DISEASE

#552
US20250276045A1
Human necessities

Composition Containing Collagen

#553
US20250276046A1
Human necessities

SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS

#554
US20250276047A1
Human necessities

METHODS OF TREATING DISEASES ASSOCIATED WITH TRAUMATIC BRAIN INJURY

#555
US20250276048A1
Human necessities

Tissue Modifier And Uses Therefor

#556
US20250276049A1
Human necessities

EGFR VACCINE CASSETTES

#557
US20250276050A1
Human necessities

VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE

#558
US20250276051A1
Human necessities

POWASSAN VIRAL ANTIGENS AND RELATED COMPOSITIONS, AND USES THEREOF TO VACCINATE AND TREAT PATIENTS

#559
US20250276052A1
Human necessities

RECONSTITUTION AND USES OF FLAVIVlRUS EPITOPES

#560
US20250276053A1
Human necessities

ROTAVIRUS VACCINES

#561
US20250276054A1
Human necessities

AVIAN INFLUENZA NANOPARTICLE IMMUNOGENIC COMPOSITIONS

#562
US20250276055A1
Human necessities

Visco-elastic Solid Formulation for Oral Delivery of a Biologically Active Agent

#563
US20250276056A1
Human necessities

CYTOLYTIC T CELL IMMUNOTHERAPY FOR HIGHLY PATHOGENIC CORONAVIRUSES

#564
US20250276057A1
Human necessities

NOVEL ALLERGEN ISOFORM VARIANTS

#565
US20250276058A1
Human necessities

NANOFIBERS TO PRIME ANTIBODY RESPONSES AND METHODS OF USING SAME

#566
US20250276059A1
Human necessities

THERAPEUTIC METHODS AND AGENTS FOR THE TREATMENT OF MYOCARDIAL INFARCTION

#567
US20250276060A1
Human necessities

SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION

#568
US20250276061A1
Human necessities

METHOD AND COMPOSITION FOR INDUCING TOLERANCE

#569
US20250276062A1
Human necessities

PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANTIBODIES

#570
US20250276063A1
Human necessities

PLACENTA-DERVIED NK CELLS AS A SENOL YTIC FOR THERAPEUTIC AND OTHER USES

#571
US20250276064A1
Human necessities

ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF

#572
US20250276065A1
Human necessities

Electro Magnetic Transducer Network in the Enhancement of Anti-infective Strategies

#573
US20250276066A1
Human necessities

METHODS, COMPOSITIONS AND COMPOUNDS FOR TREATING AGE-RELATED DISEASES AND CONDITIONS

#574
US20250276067A1
Human necessities

ANTICANCER DRUGS AND METHODS OF MAKING AND USING SAME

#575
US20250276068A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF POLYPEPTIDE CONJUGATES AND METHODS OF USES THEREOF

#576
US20250276069A1
Human necessities

HETEROBIFUNCTIONAL COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION AND METHODS FOR THEIR USE

#577
US20250276070A1
Human necessities

OPTIMIZED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS

#578
US20250276071A1
Human necessities

NANOPLATFORM FOR TARGETING INFLAMMATORY MACROPHAGES, AND COMPOSITION CONTAINING SAME FOR PREVENTING OR TREATING INFLAMMATORY DISEASES

#579
US20250276072A1
Human necessities

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

#580
US20250276073A1
Human necessities

BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)

#581
US20250276074A1
Human necessities

BRM AND BRG1 TARGETING ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF

#582
US20250276075A1
Human necessities

METHODS OF TREATING AXL-EXPRESSING CANCERS WITH ANTI-AXL ANTIBODIES, ANTIBODY FRAGMENTS AND THEIR IMMUNOCONJUGATES

#583
US20250276076A1
Human necessities

ANTI-ALPP/ALPPL2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#584
US20250276077A1
Human necessities

EPHA2 ANTIBODIES

#585
US20250276078A1
Human necessities

Camptothecin Derivative And Ligand-drug Conjugate Thereof

#586
US20250276079A1
Human necessities

COMBINATION OF ANTIBODY-DRUG CONJUGATE WITH EZH1 and/or EZH2 INHIBITOR

#587
US20250276080A1
Human necessities

GLUCAGON RECEPTOR AGONISTS AND CONJUGATES TO GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE ANTAGONISTS

#588
US20250276081A1
Human necessities

Mucin-Active Proteases and Methods of Use

#589
US20250276082A1
Human necessities

A GROUP OF B7H3 MONOCLONAL ANTIBODIES AND MEDICAL USE THEREOF

#590
US20250276083A1
Human necessities

MUSCLE-TARGETING COMPLEXES AND USES THEREOF

#591
US20250276084A1
Human necessities

HYDROPHILIC LINKERS AND CONJUGATES THEREOF

#592
US20250276085A1
Human necessities

SYNTHETIC MULTIDOMAIN PEPTIDE BIOMATERIALS THAT INHIBIT INDUCIBLE NITRIC OXIDE SYNTHASE

#593
US20250276086A1
Human necessities

LIPID NANOPARTICLES FOR TARGETED DELIVERY OF MRNA

#594
US20250276087A1
Human necessities

POLYMER-BASED NUCLEIC ACID MOLECULE DELIVERY VEHICLE HAVING IONIZATION MOIETY

#595
US20250276088A1
Human necessities

SYNERGISTIC COMBINATION OF RDCFV2 AND RDCVF2L FOR THE TREATMENT OF TAUOPATHIES

#596
US20250276089A1
Human necessities

CO-DELIVERY OF INHIBITORY NUCLEIC ACIDS AND GENOME EDITORS FOR TUMOR THERAPY

#597
US20250276090A1
Human necessities

Methods and Compositions for Genetically Modifying a Cell

#598
US20250276091A1
Human necessities

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

#599
US20250276092A1
Human necessities

METHODS AND COMPOSITIONS FOR RE-DOSING AAV USING ANTI-CD40 ANTAGONISTIC ANTIBODY TO SUPPRESS HOST ANTI-AAV ANTIBODY RESPONSE

#600
US20250276093A1
Human necessities

THERAPEUTIC ADENO-ASSOCIATED VIRUS USING CODON OPTIMIZED NUCLEIC ACID ENCODING FACTOR VIII